Table 4.
Audiological characteristics of transcutaneous and percutaneous BAHA users.
| Mean ± SD (dB) | P value | ||
|---|---|---|---|
| Transcutaneous (n = 20) | Percutaneous (n = 9) | ||
| SRT without BAHA | 61.53 ± 11.48 | 58.47 ± 12.56 | > .05 |
| SRT with BAHA | 26.50 ± 11.01 | 26.25 ± 16.20 | > .05 |
| FFA1 without BAHA | 61.68 ± 11.40 | 56.33 ± 11.99 | > .05 |
| FFA1 with BAHA | 26.20 ± 12.09 | 24.26 ± 7.11 | > .05 |
| FFA2 without BAHA | 61.08 ± 10.94 | 55.52 ± 13.92 | > .05 |
| FFA2 with BAHA | 34.15 ± 13.24 | 32.96 ± 10.66 | > .05 |
| FFA3 without BAHA | 61.53 ± 10.27 | 56.11 ± 12.85 | > .05 |
| FFA3 with BAHA | 33.35 ± 13.29 | 33.94 ± 15.04 | > .05 |
BAHA = bone-anchored hearing aid, FFA = free-field test average, SD = standard deviation, SRT = speech recognition threshold.